In a 75‑year‑old bedridden patient with septic shock, a sacral pressure ulcer, hypoxia, and suspected pulmonary embolism who is already receiving unfractionated heparin, how should the acute kidney injury and metabolic acidosis be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Acute Kidney Injury and Metabolic Acidosis in Septic Shock

In this 75-year-old patient with septic shock, AKI, and metabolic acidosis, avoid sodium bicarbonate therapy if pH ≥7.15, use continuous renal replacement therapy (CRRT) for hemodynamic instability and fluid management, continue unfractionated heparin (UFH) as it is appropriate for renal impairment, and focus on optimizing sepsis resuscitation with crystalloids and vasopressors. 1

Metabolic Acidosis Management

The Surviving Sepsis Campaign 2016 guidelines provide clear direction: do not use sodium bicarbonate therapy to improve hemodynamics or reduce vasopressor requirements in patients with hypoperfusion-induced lactic acidemia when pH ≥7.15 (weak recommendation, moderate quality evidence). 1 This applies directly to your septic shock patient, as the acidosis is likely hypoperfusion-induced from sepsis.

The guideline is silent on pH <7.15, leaving clinical judgment for severe acidemia. However, the primary focus should remain on treating the underlying sepsis rather than the acidosis itself, as metabolic acidosis in sepsis reflects both the pathophysiology and potentially iatrogenic factors from chloride-rich fluid resuscitation. 2

Acute Kidney Injury Management

Renal Replacement Therapy Decision

For this hemodynamically unstable patient in septic shock with AKI:

  • Use continuous therapies (CRRT) to facilitate fluid balance management in hemodynamically unstable septic patients (weak recommendation, very low quality evidence). 1

  • Either CRRT or intermittent hemodialysis are equivalent for sepsis-associated AKI overall, but CRRT is preferred given the septic shock state. 1

Critical caveat: Do not initiate RRT solely for elevated creatinine or oliguria without other definitive indications for dialysis (weak recommendation, low quality evidence). 1 Definitive indications include:

  • Severe hyperkalemia
  • Severe metabolic acidosis (pH <7.15 is a reasonable threshold based on the bicarbonate guidance)
  • Pulmonary edema refractory to diuretics
  • Uremic complications
  • Severe volume overload compromising oxygenation (relevant given this patient's hypoxia and suspected PE)

Fluid Resuscitation Strategy

Use crystalloids as the initial fluid choice (strong recommendation, moderate quality evidence). 1 Consider balanced crystalloids over normal saline to avoid worsening hyperchloremic metabolic acidosis, though the guideline gives only weak support for this distinction. 1

The patient likely received substantial crystalloids already; if requiring ongoing large volumes, albumin may be added (weak recommendation, low quality evidence). 1

Anticoagulation Considerations

VTE Prophylaxis with Existing Heparin Therapy

This patient is already receiving UFH for suspected pulmonary embolism, which is appropriate. The guidelines address VTE prophylaxis specifically:

In the setting of acute kidney injury with creatinine clearance <30 mL/min, use either:

  • Dalteparin (strong recommendation, high quality evidence) 1
  • Another LMWH with low renal metabolism (weak recommendation, low quality evidence) 1
  • Unfractionated heparin (UFH) (strong recommendation, high quality evidence) 1

Since this patient is already on UFH for therapeutic anticoagulation (suspected PE), this is the correct choice given the AKI. UFH does not require renal dose adjustment and can be monitored with aPTT. 3 Continue the current UFH regimen with appropriate monitoring.

Add mechanical prophylaxis (intermittent pneumatic compression devices) whenever possible in combination with pharmacologic therapy (weak recommendation, low quality evidence). 1

Supportive Management Priorities

Hemodynamic Optimization

  • Target MAP ≥65 mmHg with vasopressors (norepinephrine first-line). 1
  • Continue fluid resuscitation as long as hemodynamic parameters improve. 1

Source Control

  • Urgent debridement of the sacral pressure ulcer is critical as this is the likely sepsis source. 1

Glucose Control

  • Target blood glucose 110-180 mg/dL with insulin protocol (strong recommendation, high quality evidence). 1

Common Pitfalls to Avoid

  1. Do not give bicarbonate reflexively for metabolic acidosis with pH ≥7.15—it does not improve outcomes and may cause harm.

  2. Do not initiate RRT prematurely based solely on rising creatinine or oliguria—wait for definitive indications unless severe complications develop.

  3. Do not switch from UFH to LMWH in this patient with AKI—UFH is appropriate and does not accumulate with renal dysfunction.

  4. Do not use normal saline exclusively if ongoing large-volume resuscitation is needed—this worsens hyperchloremic acidosis. 2

  5. Do not delay source control of the infected pressure ulcer—this is fundamental to reversing septic shock and preventing further organ injury.

References

2
Research

Metabolic acidosis in sepsis.

Endocrine, metabolic & immune disorders drug targets, 2010

Related Questions

What is the appropriate management for a patient with severe sepsis, acute kidney injury (creatinine 8.65 mg/dL, estimated glomerular filtration rate 6 mL/min/1.73 m²), metabolic acidosis, hyperlactatemia, hyperglycemia (glucose 247 mg/dL), thrombocytopenia (platelet count 89 ×10⁹/L), elevated liver enzymes (ALT 214 U/L, AST 253 U/L), elevated troponin (254 ng/L), and hypoxemia (PaO₂ 60 mm Hg, O₂ saturation 89%)?
What is the recommended management for sepsis‑induced acute kidney injury?
What is the appropriate management for a patient who had fever and now presents with acute renal failure, likely due to sepsis from pneumonia?
What is the appropriate inpatient management for a patient with sepsis, acute kidney injury, metabolic acidosis, hypernatremia, and a urinalysis showing moderate budding yeast?
What is the mechanism of septic acute kidney injury?
What actions can be taken when a patient lacking decision-making capacity refuses intravenous fluids for dehydration?
Which results are abnormal in this comprehensive metabolic panel (CMP) with sodium 140 mmol/L, potassium 4.2 mmol/L, chloride 0.6 mmol/L, total CO₂ 22 mmol/L, blood urea nitrogen 43 mg/dL, creatinine 1.7 mg/dL, estimated glomerular filtration rate 43 mL/min/1.73 m², glucose 120 mg/dL, calcium 9.3 mg/dL, AST (aspartate aminotransferase) 41 U/L, ALT (alanine aminotransferase) 36 U/L, alkaline phosphatase 110 U/L, total bilirubin 0.5 mg/dL, albumin 3.9 g/dL, and total protein 6.1 g/dL?
For a patient on outpatient hemodialysis who had a permanent catheter (perm‑cath) removed and a bloodstream infection with ESBL‑producing Escherichia coli, and who has already received one week of inpatient meropenem, how many additional meropenem doses and for what total duration should be administered?
For a patient with a net‑negative fluid balance, how should albumin be replaced to replenish serum albumin without adding excess volume?
In a 66‑year‑old man with an isolated elevated follicle‑stimulating hormone (FSH) and normal luteinizing hormone (LH), total and free testosterone, and sex hormone‑binding globulin (SHBG), can testosterone replacement therapy be the cause?
Does cariprazine (Vraylar) help reduce paranoid symptoms in adults with schizoaffective disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.